Your browser doesn't support javascript.
loading
Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial.
Voci, Davide; Götschi, Andrea; Held, Ulrike; Bingisser, Roland; Colucci, Giuseppe; Duerschmied, Daniel; Fumagalli, Riccardo M; Gerber, Bernhard; Hasse, Barbara; Keller, Dagmar I; Konstantinides, Stavros V; Mach, François; Rampini, Silvana K; Righini, Marc; Robert-Ebadi, Helia; Rosemann, Thomas; Roth-Zetzsche, Stéphanie; Sebastian, Tim; Simon, Noemi R; Spirk, David; Stortecky, Stefan; Vaisnora, Lukas; Kucher, Nils; Barco, Stefano.
Afiliación
  • Voci D; Department of Angiology, University Hospital Zurich, Zurich, Switzerland.
  • Götschi A; Department of Biostatistics at Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
  • Held U; Department of Biostatistics at Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
  • Bingisser R; Emergency Department, University Hospital Basel, Basel, Switzerland.
  • Colucci G; Service of Hematology, Clinica Luganese Moncucco, Lugano, Switzerland; University of Basel, Basel, Switzerland; Clinica Sant'Anna, Sorengo, Switzerland.
  • Duerschmied D; Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University, Germany; European Center for AngioScience (ECAS) and German Center for Cardiovascular Research (DZHK) partner site Heidelberg/Mannheim
  • Fumagalli RM; Department of Angiology, University Hospital Zurich, Zurich, Switzerland.
  • Gerber B; Clinic of Hematology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland; University of Zurich, Zurich, Switzerland.
  • Hasse B; University of Zurich, Zurich, Switzerland; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Switzerland.
  • Keller DI; University of Zurich, Zurich, Switzerland; Emergency Department, University Hospital Zurich, Zurich, Switzerland.
  • Konstantinides SV; Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany; Department of Cardiology, Democritus University of Thrace, Komotini, Greece.
  • Mach F; Cardiology Division, Geneva University Hospital, Geneva, Switzerland.
  • Rampini SK; Division of Internal Medicine, University Hospital Zurich, Zurich, Switzerland.
  • Righini M; Division of Angiology and Hemostasis, Department of Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
  • Robert-Ebadi H; Division of Angiology and Hemostasis, Department of Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
  • Rosemann T; Institute of Primary Care, University of Zurich, Zurich, Switzerland.
  • Roth-Zetzsche S; Department of Angiology, University Hospital Zurich, Zurich, Switzerland.
  • Sebastian T; Department of Angiology, University Hospital Zurich, Zurich, Switzerland.
  • Simon NR; Emergency Department, University Hospital Basel, Basel, Switzerland.
  • Spirk D; Institute of Pharmacology, University of Bern, Bern, Switzerland.
  • Stortecky S; Department of Cardiology, Inselspital Bern, University of Bern, Bern, Switzerland.
  • Vaisnora L; Department of Cardiology, Inselspital Bern, University of Bern, Bern, Switzerland.
  • Kucher N; Department of Angiology, University Hospital Zurich, Zurich, Switzerland; University of Zurich, Zurich, Switzerland.
  • Barco S; Department of Angiology, University Hospital Zurich, Zurich, Switzerland; Center for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany. Electronic address: stefano.barco@usz.ch.
Thromb Res ; 221: 157-163, 2023 01.
Article en En | MEDLINE | ID: mdl-36396519

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / COVID-19 Tipo de estudio: Clinical_trials / Etiology_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Thromb Res Año: 2023 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / COVID-19 Tipo de estudio: Clinical_trials / Etiology_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Thromb Res Año: 2023 Tipo del documento: Article País de afiliación: Suiza